Neurology Devices Market by Product and Geography - Forecast and Analysis 2020-2024

神経デバイスの世界市場予測・分析2020-2024

◆タイトル:Neurology Devices Market by Product and Geography - Forecast and Analysis 2020-2024
◆商品コード:IRTNTR40120
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年11月26日
◆ページ数:171
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社の本調査レポートでは、神経デバイスの世界市場について調べ、神経デバイスの市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、神経デバイスの市場規模をセグメンテーション別(製品別(神経刺激デバイス、介入神経デバイス、脳神経外科デバイス、脳脊髄液管理デバイス、その他)、)と地域別(グローバル)に分けて算出しました。Technavio社は神経デバイスの世界市場規模が2020-2024期間中に年平均12%成長すると予測しています。
・サマリー
・レポートの範囲
・神経デバイスの市場状況
・神経デバイスの市場規模
・神経デバイスの市場予測
・神経デバイスの世界環境:ファイブフォース分析
・市場セグメンテーション:製品別(神経刺激デバイス、介入神経デバイス、脳神経外科デバイス、脳脊髄液管理デバイス、その他)
・神経デバイスの顧客状況
・主要地域別市場規模:グローバル
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...

Global Neurology Devices Market: About this market
Technavio’s neurology devices market analysis considers sales from neurostimulation devices, interventional neurology devices, neurosurgery devices, cerebrospinal fluid management devices, and other products. Our study also finds the sales of neurology devices in Asia, Europe, North America, and ROW. In 2019, the neurostimulation devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as implantable, programmable devices placed surgically to deliver electrical stimulation to the intended parts of the brain, the spinal cord will play a significant role in the neurostimulation devices segment to maintain its market position. Also, our global neurology devices market report looks at factors such as increasing prevalence of neurological disorders, growing geriatric population, increasing funding on neurology. However, high cost of neurology devices, stringent regulations, and product recall, and shortage of neurologists may hamper the growth of the neurology devices industry over the forecast period.
Global Neurology Devices Market: Overview
Increasing prevalence of neurological disorders
The prevalence of neurological disorders which include PD, MS, sleep apnea, epilepsy, brain tumors, brain aneurysm, brain stroke, and brain tumors is increasing. These disorders are associated with the central and peripheral nervous systems. Patients experience pain, neurological instability, seizures, paralysis, and muscle weakness under these conditions. Several factors including chromosomal abnormalities or congenital defects in genes cause these neurological conditions. Thus, the increasing prevalence of neurological disorders will lead to the expansion of the global neurology devices market at a CAGR of almost 12% during the forecast period.
Strong prevalence of the wearable neurology devices
The growing awareness and need for home care have encouraged the global population to adopt smart wearable devices such as smartwatches and smart bands for seamless monitoring and recording of patient health data through a wireless interface. Additionally, the recorded health data can be shared with healthcare professionals for better patient outcomes. Wearable neurology devices are used for continuous detection and monitoring of patients with neurological disorders such as seizures and PD. The US FDA has already approved an MHealth wearable device, Embrace2, which uses advanced machine learning technology to detect electrodermal activities in patients. This development is expected to have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global neurology devices market during the forecast period 2020-2024, click here.
Competitive Landscape
With the presence of several major players, the global neurology devices market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurology devices manufacturers, that include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Co., Boston Scientific Corp., Johnson & Johnson Services Inc., Medtronic Plc, MicroPort Scientific Corp., Nihon Kohden Corp., Penumbra Inc., and Stryker Corp.
Also, the neurology devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
• Value Chain Analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Neurostimulation devices – Market size and forecast 2019-2024
• Interventional neurology devices – Market size and forecast 2019-2024
• Neurosurgery Devices – Market size and forecast 2019-2024
• Cerebrospinal fluid management devices – Market size and forecast
• 2019-2024
• Others – Market size and forecast 2019-2024
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Technological advances and new product launches
• Strong penetration of wearable neurology devices
• Growing medical tourism in emerging economies
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott Laboratories
• B. Braun Melsungen AG
• Becton, Dickinson and Co.
• Boston Scientific Corp.
• Johnson & Johnson Services Inc.
• Medtronic Plc
• MicroPort Scientific Corp.
• Nihon Kohden Corp.
• Penumbra Inc.
• Stryker Corp.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global healthcare equipment market
Exhibit 02: Segments of global healthcare equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Neurostimulation devices – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Neurostimulation devices – Year-over-year growth 2020-2024 (%)
Exhibit 22: Interventional neurology devices – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Interventional neurology devices – Year-over-year growth 2020-2024 (%)
Exhibit 24: Neurosurgery devices – Market size and forecast 2019-2024 ($ millions)
Exhibit 25: Neurosurgery devices – Year-over-year growth 2020-2024 (%)
Exhibit 26: Cerebrospinal fluid management devices – Market size and forecast 2019-2024 ($ millions)
Exhibit 27: Cerebrospinal fluid management devices – Year-over-year growth 2020-2024 (%)
Exhibit 28: Others – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: Others – Year-over-year growth 2020-2024 (%)
Exhibit 30: Market opportunity by product
Exhibit 31: Customer landscape
Exhibit 32: Market share by geography 2019-2024 (%)
Exhibit 33: Geographic comparison
Exhibit 34: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: North America – Year-over-year growth 2020-2024 (%)
Exhibit 36: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 37: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 38: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 39: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 40: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 41: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Increase in the population aged 65 years and above (%)
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendors covered
Exhibit 49: Vendor classification
Exhibit 50: Market positioning of vendors
Exhibit 51: Abbott Laboratories – Vendor overview
Exhibit 52: Abbott Laboratories – Business segments
Exhibit 53: Abbott Laboratories – Organizational developments
Exhibit 54: Abbott Laboratories – Geographic focus
Exhibit 55: Abbott Laboratories – Segment focus
Exhibit 56: Abbott Laboratories – Key offerings
Exhibit 57: B. Braun Melsungen AG – Vendor overview
Exhibit 58: B. Braun Melsungen AG – Business segments
Exhibit 59: B. Braun Melsungen AG – Organizational developments
Exhibit 60: B. Braun Melsungen AG – Geographic focus
Exhibit 61: B. Braun Melsungen AG – Segment focus
Exhibit 62: B. Braun Melsungen AG – Key offerings
Exhibit 63: Becton, Dickinson and Co. – Vendor overview
Exhibit 64: Becton, Dickinson and Co. – Business segments
Exhibit 65: Becton, Dickinson and Co. – Organizational developments
Exhibit 66: Becton, Dickinson and Co. – Geographic focus
Exhibit 67: Becton, Dickinson and Co. – Segment focus
Exhibit 68: Becton, Dickinson and Co. – Key offerings
Exhibit 69: Boston Scientific Corp. – Vendor overview
Exhibit 70: Boston Scientific Corp. – Business segments
Exhibit 71: Boston Scientific Corp. – Organizational developments
Exhibit 72: Boston Scientific Corp. – Geographic focus
Exhibit 73: Boston Scientific Corp. – Segment focus
Exhibit 74: Boston Scientific Corp. – Key offerings
Exhibit 75: Johnson & Johnson Services Inc. – Vendor overview
Exhibit 76: Johnson & Johnson Services Inc. – Business segments
Exhibit 77: Johnson & Johnson Services Inc. – Organizational developments
Exhibit 78: Johnson & Johnson Services Inc. – Geographic focus
Exhibit 79: Johnson & Johnson Services Inc. – Segment focus
Exhibit 80: Johnson & Johnson Services Inc. – Key offerings
Exhibit 81: Medtronic Plc – Vendor overview
Exhibit 82: Medtronic Plc – Business segments
Exhibit 83: Medtronic Plc – Organizational developments
Exhibit 84: Medtronic Plc – Geographic focus
Exhibit 85: Medtronic Plc – Segment focus
Exhibit 86: Medtronic Plc – Key offerings
Exhibit 87: MicroPort Scientific Corp. – Vendor overview
Exhibit 88: MicroPort Scientific Corp. – Business segments
Exhibit 89: MicroPort Scientific Corp. – Organizational developments
Exhibit 90: MicroPort Scientific Corp. – Geographic focus
Exhibit 91: MicroPort Scientific Corp. – Segment focus
Exhibit 92: MicroPort Scientific Corp. – Key offerings
Exhibit 93: Nihon Kohden Corp. – Vendor overview
Exhibit 94: Nihon Kohden Corp. – Business segments
Exhibit 95: Nihon Kohden Corp. – Organizational developments
Exhibit 96: Nihon Kohden Corp. – Geographic focus
Exhibit 97: Nihon Kohden Corp. – Segment focus
Exhibit 98: Nihon Kohden Corp. – Key offerings
Exhibit 99: Penumbra Inc. – Vendor overview
Exhibit 100: Penumbra Inc. – Business segments
Exhibit 101: Penumbra Inc. – Organizational developments
Exhibit 102: Penumbra Inc. – Geographic focus
Exhibit 103: Penumbra Inc. – Segment focus
Exhibit 104: Penumbra Inc. – Key offerings
Exhibit 105: Stryker Corp. – Vendor overview
Exhibit 106: Stryker Corp. – Business segments
Exhibit 107: Stryker Corp. – Organizational developments
Exhibit 108: Stryker Corp. – Geographic focus
Exhibit 109: Stryker Corp. – Segment focus
Exhibit 110: Stryker Corp. – Key offerings
Exhibit 111: Validation techniques employed for market sizing
Exhibit 112: Definition of market positioning of vendors



【掲載企業】

Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Co., Boston Scientific Corp., Johnson & Johnson Services Inc., Medtronic Plc, MicroPort Scientific Corp., Nihon Kohden Corp., Penumbra Inc., and Stryker Corp.

★調査レポート[神経デバイスの世界市場予測・分析2020-2024] (Neurology Devices Market by Product and Geography - Forecast and Analysis 2020-2024 / IRTNTR40120)販売に関する免責事項
[神経デバイスの世界市場予測・分析2020-2024] (Neurology Devices Market by Product and Geography - Forecast and Analysis 2020-2024 / IRTNTR40120)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆